Intracellular Sequestration of the NKG2D Ligand ULBP3 by Human Cytomegalovirus

被引:63
作者
Bennett, Neil J. [1 ]
Ashiru, Omodele [2 ]
Morgan, Fiona J. E. [1 ]
Pang, Yin [1 ]
Okecha, Georgina [1 ]
Eagle, Rob A. [3 ]
Trowsdale, John [3 ]
Sissons, J. G. Patrick [1 ]
Wills, Mark R. [1 ]
机构
[1] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[3] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
基金
英国惠康基金;
关键词
NATURAL-KILLER-CELLS; ACTIVATING RECEPTOR NKG2D; CLASS-I MOLECULES; T-CELLS; MOUSE CYTOMEGALOVIRUS; DOWN-REGULATION; NK CELLS; HLA-E; MURINE CYTOMEGALOVIRUS; SURFACE EXPRESSION;
D O I
10.4049/jimmunol.1000789
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human CMV (HCMV) encodes multiple genes that control NK cell activation and cytotoxicity. Some of these HCMV-encoded gene products modulate NK cell activity as ligands expressed at the cell surface that engage inhibitory NK cell receptors, whereas others prevent the infected cell from upregulating ligands that bind to activating NK cell receptors. A major activating NKR is the homodimeric NKG2D receptor, which has eight distinct natural ligands in humans. It was shown that HCMV is able to prevent the surface expression of five of these ligands (MIC A/B and ULBP1, 2, and 6). In this article, we show that the HCMV gene product UL142 can prevent cell surface expression of ULBP3 during infection. We further show that UL142 interacts with ULBP3 and mediates its intracellular retention in a compartment that colocalizes with markers of the cis-Golgi complex. In doing so, UL142 prevents ULBP3 trafficking to the surface and protects transfected cells from NK-mediated cytotoxicity. This is the first description of a viral gene able to mediate downregulation of ULBP3. The Journal of Immunology, 2010, 185: 1093-1102.
引用
收藏
页码:1093 / 1102
页数:10
相关论文
共 69 条
[41]   Receptors for HLA class-I molecules in human natural killer cells [J].
Moretta, A ;
Bottino, C ;
Vitale, M ;
Pende, D ;
Biassoni, R ;
Mingari, MC ;
Moretta, L .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :619-648
[42]  
Moretta Lorenzo, 2001, Current Opinion in Pharmacology, V1, P387, DOI 10.1016/S1471-4892(01)00067-4
[43]   Structure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D Ligands [J].
Mueller, Steffen ;
Zocher, Georg ;
Steinle, Alexander ;
Stehle, Thilo .
PLOS PATHOGENS, 2010, 6 (01)
[44]   Diverse Herpesvirus MicroRNAs Target the Stress-induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells [J].
Nachmani, Daphna ;
Stern-Ginossar, Noam ;
Sarid, Ronit ;
Mandelboim, Ofer .
CELL HOST & MICROBE, 2009, 5 (04) :376-385
[45]   Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60 [J].
O'Callaghan, CA ;
Cerwenka, A ;
Willcox, BE ;
Lanier, LL ;
Bjorkman, PJ .
IMMUNITY, 2001, 15 (02) :201-211
[46]   Population study of allelic diversity in the human MHC class I-related MIC-A gene [J].
Petersdorf, EW ;
Shuler, KB ;
Longton, GM ;
Spies, T ;
Hansen, JA .
IMMUNOGENETICS, 1999, 49 (7-8) :605-612
[47]   Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis [J].
Pinto, Amelia K. ;
Munks, Michael W. ;
Koszinowski, Ulrich H. ;
Hill, Ann B. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (05) :3225-3234
[48]   HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors [J].
Posch, PE ;
Borrego, F ;
Brooks, AG ;
Coligan, JE .
JOURNAL OF BIOMEDICAL SCIENCE, 1998, 5 (05) :321-331
[49]   The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- cells [J].
Prod'homme, Virginie ;
Griffin, Cora ;
Aicheler, Rebecca J. ;
Wang, Eddie C. Y. ;
McSharry, Brian P. ;
Rickards, Carole R. ;
Stanton, Richard J. ;
Borysiewicz, Leszek K. ;
Lopez-Botet, Miguel ;
Wilkinson, Gavin W. G. ;
Tomasec, Peter .
JOURNAL OF IMMUNOLOGY, 2007, 178 (07) :4473-4481
[50]   Antigens and immunoevasins: Opponents in cytomegalovirus immune surveillance [J].
Reddehase, MJ .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (11) :831-844